Document is current
Any future updates will be listed below
-
Authors
Benjamin, Kynon J. M.
Arora, Ria
Feltrin, Arthur S. http://orcid.org/0000-0002-1810-2203
Pertea, Geo http://orcid.org/0000-0002-3210-7182
Giles, Hunter H. http://orcid.org/0000-0002-2340-5444
Stolz, Joshua M.
D’Ignazio, Laura
Collado-Torres, Leonardo
Shin, Joo Heon http://orcid.org/0000-0002-5563-8605
Ulrich, William S.
Hyde, Thomas M.
Kleinman, Joel E. http://orcid.org/0000-0002-4210-6052
Weinberger, Daniel R. http://orcid.org/0000-0003-2409-2969
Paquola, Apuã C. M.
Erwin, Jennifer A. http://orcid.org/0000-0002-6784-9290
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation
- License Information
-
More Information
Article History
Received: 21 November 2022
Accepted: 15 April 2024
First Online: 10 May 2024
Competing interests
: D.R.W. serves on the Scientific Advisory Boards of Sage Therapeutics and Pasithea Therapeutics. J.E.K. is a member of a drug monitoring committee for an antipsychotic drug trial for Merck. All other authors declare no competing interests.
